Immunic Therapeutics

Name: Immunic Therapeutics
Address: 1200 Avenue of the Americas, Suite 200, New York, NY, NY10036, US
Telephone: +4989208047700

Home
United States
New York, NY
Immunic Therapeutics

Call Directions Website

Immunic (Nasdaq: IMUX) is a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases.

11/04/2026

🧠 What We Learned at the 10th Joint ACTRIMS-ECTRIMS Meeting 2026

🔊 Following , Proactive active spoke with our CMO Dr. Mike Panzara about key takeaways from this year’s meeting — including our presence at the congress as well as new multiple sclerosis (MS) clinical, biomarker, and preclinical data presented across four poster presentations.

👉 Watch the full interview here: https://bit.ly/4sDQogb

ACTRIMS European Committee for Treatment & Research in Multiple Sclerosis

10/31/2026

🎃 The future should not be scary. 👻

For many people living with ( ), uncertainty about what the future may hold is not a seasonal fright. It is a daily reality.

That's why we are committed to advancing research aimed at helping people with MS look to the future with greater confidence, less uncertainty and more hope.

Happy Halloween from the team. 🧡

10/30/2026

( ) is not a single biological story. Its biology has many layers. 🧬

Many things may shape each person’s experience of MS, including their genes, their environment, their resilience, progression beyond relapses, immune cell activity, and inflammation.

At , we listen first, then act on what patients, their families, and the physicians who treat them share. Our research on and explores different dimensions of the disease because deeper understanding is the first step toward improving everyday life of patients.

10/27/2026

🔬 That’s a wrap on !

It was a busy and rewarding congress for the team last week, filled with scientific exchange, poster presentations and valuable conversations with colleagues and stakeholders from across the ( ) community.

🎗️ We presented four posters covering new findings from our investigational MS development program, with particularly strong engagement during our two paper poster presentations.

🤝 Our booth was busy throughout the meeting, with many opportunities to connect and exchange perspectives.

Thank you to everyone who stopped by and helped make the 10th Joint - Meeting such a successful conference for us!

ACTRIMS European Committee for Treatment & Research in Multiple Sclerosis

10/26/2026

✨ Marking Jaa Roberson’s appointment as the new Chief People Officer of , showcased on the tower in New York City. 🏙️

Welcome again, Jaa, to team ! We are looking forward to our next phase of growth together. And thank you, Nasdaq, for the continued support.

10/23/2026

🧠 In our series, we take a closer look at biological processes relevant to ( ).

🔬 One important area of research is . In relapsing MS, inflammation in specific areas of the brain and spinal cord involves activated immune cells, including T and B cells, and is associated with inflammatory disease activity.

When highly active, these cells require large amounts of – essential building blocks that support their function and growth. is a key enzyme in pyrimidine synthesis. Because DHODH supports this process in highly active immune cells, investigating DHODH inhibition is of interest as a way to regulate immune-cell activity associated with inflammation in relapsing MS ( ).

🎗️ Each new discovery helps build a more complete picture of the disease and the challenges people living with MS continue to face.

10/22/2026

🔬 Day 2 at .

From scientific sessions and poster presentations to discussions with colleagues from across the ( ) community, the meeting continues to provide valuable opportunities for learning, collaboration and scientific exchange.

🎥 Here are a few impressions from the 10th Joint ACTRIMS-ECTRIMS Meeting in Toronto 🇨🇦.

📍 Visit us at booth #516 to learn more about our investigational MS program.

ACTRIMS European Committee for Treatment & Research in Multiple Sclerosis

Address

1200 Avenue Of The Americas, Suite 200
New York, NY
NY10036

Telephone

+4989208047700

Website

https://www.imux.com/

Alerts

Be the first to know and let us send you an email when Immunic Therapeutics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.